BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9130629)

  • 1. Interferon-gamma is essential for the development of cerebral malaria.
    Rudin W; Favre N; Bordmann G; Ryffel B
    Eur J Immunol; 1997 Apr; 27(4):810-5. PubMed ID: 9130629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response.
    Rudin W; Eugster HP; Bordmann G; Bonato J; Müller M; Yamage M; Ryffel B
    Am J Pathol; 1997 Jan; 150(1):257-66. PubMed ID: 9006341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria.
    Lucas R; Juillard P; Decoster E; Redard M; Burger D; Donati Y; Giroud C; Monso-Hinard C; De Kesel T; Buurman WA; Moore MW; Dayer JM; Fiers W; Bluethmann H; Grau GE
    Eur J Immunol; 1997 Jul; 27(7):1719-25. PubMed ID: 9247583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
    Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12Rβ2 is essential for the development of experimental cerebral malaria.
    Fauconnier M; Palomo J; Bourigault ML; Meme S; Szeremeta F; Beloeil JC; Danneels A; Charron S; Rihet P; Ryffel B; Quesniaux VF
    J Immunol; 2012 Feb; 188(4):1905-14. PubMed ID: 22238458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice.
    Vigário AM; Belnoue E; Grüner AC; Mauduit M; Kayibanda M; Deschemin JC; Marussig M; Snounou G; Mazier D; Gresser I; Rénia L
    J Immunol; 2007 May; 178(10):6416-25. PubMed ID: 17475871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
    Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection.
    Amani V; Vigário AM; Belnoue E; Marussig M; Fonseca L; Mazier D; Rénia L
    Eur J Immunol; 2000 Jun; 30(6):1646-55. PubMed ID: 10898501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic susceptibility to cerebral malaria.
    Lou J; Gasche Y; Zheng L; Critico B; Monso-Hinard C; Juillard P; Morel P; Buurman WA; Grau GE
    Eur J Immunol; 1998 Dec; 28(12):3989-4000. PubMed ID: 9862335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and Nonhematopoietic Compartments.
    Villegas-Mendez A; Strangward P; Shaw TN; Rajkovic I; Tosevski V; Forman R; Muller W; Couper KN
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28874445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ICAM-1 (CD54) in the development of murine cerebral malaria.
    Favre N; Da Laperousaz C; Ryffel B; Weiss NA; Imhof BA; Rudin W; Lucas R; Piguet PF
    Microbes Infect; 1999 Oct; 1(12):961-8. PubMed ID: 10617927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria.
    Belnoue E; Potter SM; Rosa DS; Mauduit M; Grüner AC; Kayibanda M; Mitchell AJ; Hunt NH; Rénia L
    Parasite Immunol; 2008 Oct; 30(10):544-53. PubMed ID: 18665903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain.
    Li J; Chang WL; Sun G; Chen HL; Specian RD; Berney SM; Kimpel D; Granger DN; van der Heyde HC
    J Investig Med; 2003 May; 51(3):128-40. PubMed ID: 12769195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
    Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
    J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cytokine production is associated with protection from murine cerebral malaria.
    Mitchell AJ; Hansen AM; Hee L; Ball HJ; Potter SM; Walker JC; Hunt NH
    Infect Immun; 2005 Sep; 73(9):5645-53. PubMed ID: 16113282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.
    Settles EW; Moser LA; Harris TH; Knoll LJ
    Infect Immun; 2014 Mar; 82(3):1343-53. PubMed ID: 24396042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines.
    Van den Steen PE; Deroost K; Van Aelst I; Geurts N; Martens E; Struyf S; Nie CQ; Hansen DS; Matthys P; Van Damme J; Opdenakker G
    Eur J Immunol; 2008 Apr; 38(4):1082-95. PubMed ID: 18383042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
    Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
    Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
    Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
    Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria.
    Potter S; Chan-Ling T; Ball HJ; Mansour H; Mitchell A; Maluish L; Hunt NH
    Int J Parasitol; 2006 Apr; 36(4):485-96. PubMed ID: 16500656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.